£5.0M
The funding round was led by PXN Ventures with participation from IQ Capital and Northern Gritstone.
I
Imperagen
Imperagen engineers better enzymes faster using quantum physics and artificial intelligence.
Manchester, UK—Founded 2021
£5.0MTotal raised
Imperagen is a Manchester-based techbio company that combines quantum physics, artificial intelligence, and automated laboratories to engineer enzymes for various industrial applications.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Imperagen's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
GL
Guy Levy-Yurista
CEO
Andrew Almond
Researcher
Andrew brings academic research and startup founding experience, having held roles at Imperagen, C4X Discovery, and The University of Manchester.
LinkedIn
TE
Tim Eyes
Researcher
Tim is co-founder and chief product officer at Imperagen. He previously held research roles at The University of Manchester and worked as an R and D scientist at Novartis.
LinkedIn